Article
Genetic evidence that nitric oxide modulates homocysteine: the NOS3 894TT genotype is a risk factor for hyperhomocystenemia.
Arteriosclerosis, thrombosis, and vascular biology - 1 Jun 2003
Brown Karen S, Kluijtmans Leo A J, Young Ian S, Woodside Jayne, Yarnell John W G, McMaster Dorothy, Murray Liam, Evans Alun E, Boreham Colin A, McNulty Helene, Strain J J, Mitchell Laura E, Whitehead Alexander S
Abstract excerpt
OBJECTIVE: Mild hyperhomocystenemia is an independent, graded risk factor for cardiovascular disease. Genetic determinants of hyperhomocystenemia include functional polymorphisms in several folate/homocysteine metabolic enzymes. Nitric oxide may also modulate plasma homocysteine (tHcy) concentrations, either by direct inhibition of methionine synthase or via an indirect effect on folate catabolism. METHODS AND...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
